Raymond James Financial
EDVA

Raymond James Financial’s Endovia Health Sciences, Inc. EDVA Stock Holding History

Raymond James Financial’s Portfolio EDVA Stock Details EDVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-15
Closed -$229 – 6425
2025
Q2 		$229 Buy
+15
New +$246 ﹤0.01% 6768

Other funds holding EDVA

CL
Choreo LLC Rockford, Illinois $9.11B AUM 26.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Raymond James Financial's EDVA Position: Q3 2025 in Review

Raymond James Financial sold out of Endovia Health Sciences, Inc. (EDVA) in Q3 2025, closing a stake of 15 shares — an estimated $229 sold.

Raymond James Financial first reported a position in EDVA in Q2 2025 and held it in 1 quarter. The position peaked at $229 in Q2 2025. 17 funds tracked by Wall St. Rank hold EDVA as of Q3 2025.

  • Raymond James Financial reported no remaining Endovia Health Sciences, Inc. position as of Q3 2025 after selling out during the quarter.
  • Raymond James Financial sold 15 Endovia Health Sciences, Inc. shares in Q3 2025, an estimated $229.
  • Raymond James Financial first reported a position in Endovia Health Sciences, Inc. in Q2 2025 and held it in 1 quarter.
  • Raymond James Financial's Endovia Health Sciences, Inc. position peaked at $229 in Q2 2025.
  • 17 funds tracked by Wall St. Rank held Endovia Health Sciences, Inc. as of Q3 2025.

Based on Raymond James Financial's 13F filing for Q3 2025, filed 14 Nov 2025.